Last deal

$225.M

Amount

Series A

Stage

12.12.2016

Date

1

all rounds

$225.M

Total amount

General

About Company
BlueRock Therapeutics is a regenerative medicine company that develops induced pluripotent stem cell therapies.

Industry

Sector :

Subsector :

Keywords :

Also Known As

BlueRock

founded date

01.01.2016

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company's cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, and immunology indications. BlueRock Therapeutics' culture is defined by scientific innovation, the highest ethical standards, and an urgency to bring transformative treatments to all who would benefit.
Contacts